Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Update

Predictive Oncology Inc. (NASDAQ:POAI) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 626,700 shares, a growth of 36.9% from the January 15th total of 457,800 shares. Currently, 9.6% of the shares of the company are sold short. Based on an average daily volume of 1,910,000 shares, the days-to-cover ratio is currently 0.3 days.

Predictive Oncology Trading Up 9.5 %

Shares of POAI stock traded up $0.14 on Friday, hitting $1.62. 308,911 shares of the stock were exchanged, compared to its average volume of 2,838,906. The firm has a market capitalization of $10.81 million, a PE ratio of -0.53 and a beta of 1.25. Predictive Oncology has a one year low of $0.55 and a one year high of $3.76. The firm’s 50 day moving average is $1.18 and its two-hundred day moving average is $0.94.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “neutral” rating on shares of Predictive Oncology in a research note on Friday, November 15th.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.